Merck cuts contractors at NC vax plant; Marksans buys Time-Cap Labs; Attix gets FDA warning;

> Merck ($MRK) acknowledged it is cutting an undisclosed number of contract jobs at a vaccine plant in North Carolina. Report

> India's Marksans Pharma says it has acquired U.S. generics and OTC company, Time-Cap Laboratories for an undisclosed amount. Story

> Novartis ($NVS) is voluntarily recalling about 75,000 packs of asthma drug Foradil Aerolizer that it manufactured at a plant in Switzerland for Merck because the formoterol fumarate inhalation powder was out of spec for particle size during stability tests. Notice and Notice

> Here's a Q&A from ICH about its GMP guidance for API manufacturing. Document (PDF)

> West-Ward is voluntarily recalling 14,649 cartons of fentanyl citrate vials after they failed impurities and degradation specs at 12 months. Report

> German glass and plastic pharmaceutical packaging manufacturer Gerresheimer will sell its borosilicate glass tubing business to Corning for €196 million and then enter into a 10-supply agreement with Corning for the products. Report

> AstraZeneca ($AZN) is recalling 34,524 bottles of Nexium after a pharmacy discovered in a bottle a tablet of the antipsychotic Seroquel XR. Notice

> The FDA has sent a warning letter to Canadian API repackager Attix Pharmaceuticals. Letter